2022
DOI: 10.1021/acs.analchem.2c02556
|View full text |Cite
|
Sign up to set email alerts
|

Adaptable Microfluidic Vessel-on-a-Chip Platform for Investigating Tumor Metastatic Transport in Bloodstream

Abstract: Cancer metastasis counts for 90% of cancer fatalities, and its development process is still a mystery. The dynamic process of tumor metastatic transport in the blood vessel is not well understood, in which some biomechanical factors, such as shear stress and various flow patterns, may have significant impacts. Here, we report a microfluidic vessel-on-achip platform for recapitulating several key metastatic steps of tumor cells in blood vessels on the same chip, including intravasation, circulating tumor cell (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 43 publications
0
9
0
Order By: Relevance
“…In recent years, considerable progress has been achieved in utilizing microfluidic technology in the research of urinary tumor drug screening, tumor metastasis, and glomerulus-on-chip development [ [127] , [128] , [129] , [130] ]. Microfluidic models of the urinary systems have enriched the understanding of microenvironments from single-cell cultures to co-culture involving two types of cells based on membranes to multicellular co-culture based on microcolumns or 3D biological printing technology.…”
Section: Challenges and Future Directionsmentioning
confidence: 99%
“…In recent years, considerable progress has been achieved in utilizing microfluidic technology in the research of urinary tumor drug screening, tumor metastasis, and glomerulus-on-chip development [ [127] , [128] , [129] , [130] ]. Microfluidic models of the urinary systems have enriched the understanding of microenvironments from single-cell cultures to co-culture involving two types of cells based on membranes to multicellular co-culture based on microcolumns or 3D biological printing technology.…”
Section: Challenges and Future Directionsmentioning
confidence: 99%
“…Recently, a two-step seeding method was developed to generate perfusable MVNs with physiological-like small diameters, where tumor cell clusters (containing 2-4 cells) were trapped and tracked to monitor extravasation (91). Another vessel-on-a-chip platform was developed to study CTC and endothelium interactions (43). Prostate cancer (PC3) single cells or clusters were perfused through an EC-coated channel with a diameter over 200 µm and extravasated under HGF stimulation.…”
Section: Extravasation Of Tumor Cell Clusters and Other Recent Studiesmentioning
confidence: 99%
“…The first method builds blood vessels using endothelial cells to line the constructed channels with desired geometries in the hydrogel. With this method, vessels with diameters ranging from a few hundred micrometers to a few millimeters can be achieved. For example, Kinstlinger et al used sacrificial materials to build millimeter-scale channels in the hydrogel with 3D printing technology. After seeding the human umbilical vein endothelial cells (HUVECs) to fully cover the channel inner surface, a perfusable dendritic vascular network was constructed in vitro.…”
Section: Introductionmentioning
confidence: 99%
“…After template removal and cell seeding, the patient-derived vessel model could be rapidly reconstituted in vitro for personalized medicine study . These models not only realized 3D vessel–tissue interface but also make it possible to study the vessel–tissue interaction at the cellular level. , However, due to the limited resolution of the fabrication technology and the difficulty of perfusing cells into thin channels, it is difficult to construct capillary vessels with complicated structures and diameters below 100 μm …”
Section: Introductionmentioning
confidence: 99%